ADAR1 Capital Management, LLC 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:47 pm Purchase |
2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB |
ADAR1 Capital Management, LLC | 3,684,708 8.510% |
3,684,708 (New Position) |
Filing |